HB 929 proposes to revise laws related to chiropractic practitioners in Montana. The bill would establish an optional license endorsement allowing chiropractors who meet specific requirements to prescribe a limited formulary of noncontrolled, nonscheduled drugs. These drugs include items like over-the-counter analgesics, prescription nonsteroidal anti-inflammatory drugs, and muscle relaxants, intended for musculoskeletal treatment and pain. The Board of Chiropractors would be responsible for establishing the educational qualifications, application procedures, and prescribing protocols for this endorsement, for which a fee may be assessed.
HB 851 proposes to create a new state agency called the Department of Health Services. This new department would take over specific human services functions currently managed by the Department of Public Health and Human Services. These transferred responsibilities include the administration of developmental disabilities services, mental health services (like the Montana State Hospital), chemical dependency services, and veterans' long-term care facilities. The bill also provides an appropriation for the new department, grants it rulemaking authority, and requires its contracts to include dispute resolution clauses.
HB 947 requires most individual health insurance policies in Montana to cover continuous glucose monitors (CGMs) and their supplies for people diagnosed with type I or type II diabetes when medically necessary, as prescribed by a healthcare provider. The bill prohibits insurers from denying coverage based on diabetes severity or insulin dependence, and bans special deductibles or limits specifically for CGMs - though standard deductibles may still apply. This affects diabetes patients covered by individual disability, health, or membership insurance plans (excluding Medicare supplements, hospital indemnity, or long-term care policies). The law aims to ensure consistent access to these critical blood sugar monitoring tools without discriminatory coverage barriers.
HB 274 sought to establish a medical respite care program in Montana for homeless individuals who are eligible for Medicaid. This program would have provided short-term housing in residential facilities with supportive medical services for those recovering from illness or injury but not requiring hospitalization. Services would have included treatment plan monitoring, medication management, immunizations, discharge planning, and transportation for medical appointments. The bill directed the Department of Public Health and Human Services to seek federal approval for the program and to report annually on its costs and the number of individuals served.
HB 758 aims to protect health benefit plan enrollees from balance billing for out-of-network ground ambulance services. It prohibits ambulance services from billing enrollees more than their in-network cost-sharing for covered transportation. The bill requires insurers to pay ambulance providers directly, caps out-of-pocket costs for these services at $100, and ensures these costs count towards deductibles. It also mandates that insurers reimburse ambulance services at established local rates or at least 400% of the Medicare rate if no contracted rate exists, and requires the state to create a public database of local ambulance rates.
HB 783 aimed to revise health insurance laws by requiring coverage for specific conditions and treatments. It would have mandated individual health insurance policies to cover glucagon-like peptide-1 receptor agonists and treatments for polycystic ovary syndrome when medically necessary, including for diagnoses of diabetes or class 3 obesity. While allowing standard cost-sharing and cost containment measures, the bill prohibited special limitations on glucagon-like peptide-1 receptor agonists. Additionally, it sought to add other mandatory coverages, such as fertility preservation services and therapies for Down syndrome, to state group health plans. The bill would have affected individuals with these conditions and those covered by applicable health insurance policies in the state.
HB 199 proposed to modify the composition of the Montana State Board of Medical Examiners. The bill aimed to reduce the number of doctor of medicine members on the board from five to four. Concurrently, it sought to increase the number of physician assistant members from one to two. This adjustment would directly affect the representation of these medical professionals on the 12-member board.
House Bill 565, also known as the "Building Families Act," would have required certain health insurance policies in Montana to cover the diagnosis and treatment of infertility, including in vitro fertilization (IVF). This mandate would have applied to small group, large group, and individual health insurance policies issued or renewed in the state. The bill defined infertility based on factors like age and time trying to conceive, or a physician's findings. It set a lifetime coverage minimum of at least $40,000 for fertilization services and aimed to ensure fertility coverage was not subject to different limitations than other medical benefits.
HB 273, the "Montana Medical Debt Patient Protection Act," aimed to limit how health care providers and third-party collectors pursue medical debt from patients in Montana. The bill would have prohibited certain collection actions, including wage garnishment, placing liens on a patient's primary residence, and reporting adverse information to credit agencies. It also mandated a 180-day waiting period after the first bill before "extraordinary collection actions," such as filing lawsuits or selling debt, could begin, along with requiring a 30-day notice to the patient. Additionally, it sought to provide patients with an opportunity to appeal insurance decisions before a bill went to collections.
HB 943 establishes the Montana Rare Disease Advisory Council within the Department of Public Health and Human Services. This 17-member council, composed of patients, caregivers, medical professionals, researchers, and other stakeholders, will provide guidance, education, and recommendations on the needs of individuals with rare diseases in Montana. Its duties include surveying patient needs, developing policy recommendations for improved access to care and treatment, publishing resources, and identifying research opportunities. The council is required to meet regularly and submit annual reports to the Governor and Legislature, and the bill includes an appropriation to cover initial costs.